aibio.space Newsroom
Company updates that fit no single desk: management changes, pipeline and partnership updates, investor events and other filings.
Sources: SEC filings and company press releases, with wires, trade press and court dockets used as leads and confirmed against a filing. The desk follows our editorial standards. 206 stories so far.
Latest stories
- Processa clears VT-7208 CSU IND and names a new executive chair
- Kiora in-licenses late-stage KIO-401 for retinal artery occlusion
- Azitra expands ATR-04 trial to rash from KRAS and MEK inhibitors
- Dermata enrolls first participant in Tome Clearing Treatment trial
- MetaVia to present Phase 1 DA-1726 data at Precision Liver Symposium
- Jaguar Health adds six-fold stock plan increase ahead of November vote
- Genprex to present TUSC2 aging research at GSA 2026 meeting
- Lifeward names Ronen Tsimerman chief financial officer
- Aptevo says ten frontline AML patients on mipletamig reached stem cell transplant
- Neuphoria extends its rights agreement to October 27, 2027
- AquaBounty's preferred stock converts into 8,077,043 common shares
- Genprex reports mouse research linking TUSC2 to healthy brain aging
- Quoin publishes peer-reviewed paper on QRX003 in Netherton Syndrome
- Premier Air Charter's chief financial officer resigns, CEO named interim
- Two Polomar Health directors resign, leaving three on the board
- VivoSim amends Organovo lease, giving up part of its San Diego office
- Adial adjourns annual meeting again as Nasdaq approval is pending
- Velocity Bioworks completes NMR feasibility test with LarmorBio
- EMA grants orphan drug designation for QRX003 in peeling skin syndrome
- Aptevo to present CD40 multispecific platform data at SITC 2026
- MetaVia appoints Sarah Browne as chief medical officer
- Bluejay completes Toray manufacturing site ahead of deadline
- Phio completes first commercial-scale cGMP batch of PH-762 drug substance
- BioRestorative appoints Donald J. Currie to its board
- BioNexus signs exclusive Malaysian healthcare licence for CogniAI
- VivoSim Labs stockholders elect two directors and approve split range
- 60 Degrees outlines next steps after its babesiosis hospital study interim analysis
- Bluejay reports SYMON-II baseline patient characteristics
- Global Innovative Platforms appoints David R. Wells as fractional chief financial officer
- Kairos Pharma reports positive interim Phase 2 data for ENV-105 in prostate cancer
- NOMAD launches a 26-stop mobile power demonstration tour
- Sonoma Pharmaceuticals adopts new Section 382 rights agreement
- Apimeds unit MindWave signs AssureChain deal with BlockAssure
- Aibotics agrees to acquire Empulser for Series C preferred stock
- Silo Pharma buys Norsight software assets for a warrant
- Azitra advances ATR-04 trial to Cohort 2 after safety review
- Scientific Industries signs CFO agreement and extends two others
- Aethlon stockholders approve 200,000,000 authorized common shares
- Apimeds names Eric Sherb chief financial officer
- OSR Health chief scientific officer resigns, effective immediately
aibio